Shane Kovacs

Shane Kovacs

Chief Operating and Financial OfficeratOlema Pharmaceuticals· In proxies 2022–2025

Pay in FY2025-56% from the year before · Olema Pharmaceuticals stock +328.8% the same year

Shane Kovacs was paid $1.9M in FY2025 (Dec), down 56%. Olema Pharmaceuticals stock rose 328.8% that year.

Pay$100 in the stock at the end of FY21 → $267
Pay is from the Summary Compensation Table of each Olema Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Olema PharmaceuticalsPublic company · 4 yr
    • Chief Operating and Financial Officer2022 – Present · 4 yrStock in role -22%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?